Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Embryonic Stem Cells00:57

Embryonic Stem Cells

4.7K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.7K
Embryonic Stem Cells00:58

Embryonic Stem Cells

32.1K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K
Stem Cell Culture01:17

Stem Cell Culture

6.0K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.0K
Adult Stem Cells01:33

Adult Stem Cells

33.4K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.4K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.4K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Ethics and Regulation of Human Brain Organoid Research: Recommendations from the Asia Pacific Neuroethics Working Group.

Asian bioethics review·2026
Same author

Drawing lines: how the public defines "Serious" genetic conditions for reproductive testing.

European journal of human genetics : EJHG·2026
Same author

Factors that delay discovery in cases of death at home in Japan.

Legal medicine (Tokyo, Japan)·2026
Same author

Japanese attitudes toward human brain organoid research: broad support amid ethical concerns.

Frontiers in genetics·2026
Same author

Normalising transparency: an argument for requiring generative AI use declarations in all manuscripts-with a call for commentaries.

Journal of medical ethics·2026
Same author

Transparency Is Not Enough: structural Risks in the Normalization of Growth Attenuation Therapy.

The American journal of bioethics : AJOB·2026

相关实验视频

Updated: Jan 16, 2026

Derivation of Human Embryonic Stem Cells by Immunosurgery
11:56

Derivation of Human Embryonic Stem Cells by Immunosurgery

Published on: December 13, 2007

34.6K

基于人类干细胞的胚胎模型研究:伦理和法规

Chie Kobayashi1, Shu Ishida1, Tsutomu Sawai2,3,4

  • 1Uehiro Division for Applied Ethics, Graduate School of Humanities and Social Sciences, Hiroshima University, Higashihiroshima, Japan.

Methods in molecular biology (Clifton, N.J.)
|October 3, 2025
PubMed
概括

基于干细胞的胚胎模型 (SCBEMs) 需要仔细的伦理和监管监督. 这项工作调查了规范性问题,绘制了伦理问题,并为负责任的SCBEM研究进步和公众信任提出了治理框架.

关键词:
胚胎干细胞是一种胚胎干细胞.人类的繁殖人类的繁殖.诱导的多能干细胞干细胞经过知情同意的同意.他们的道德地位,道德地位.公众对公众的信任.负责任的科学 负责任的科学干细胞研究的研究.基于干细胞的胚胎模型技术和道德的变化.

更多相关视频

Protocol for Human Blastoids Modeling Blastocyst Development and Implantation
12:09

Protocol for Human Blastoids Modeling Blastocyst Development and Implantation

Published on: August 10, 2022

7.3K
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

13.1K

相关实验视频

Last Updated: Jan 16, 2026

Derivation of Human Embryonic Stem Cells by Immunosurgery
11:56

Derivation of Human Embryonic Stem Cells by Immunosurgery

Published on: December 13, 2007

34.6K
Protocol for Human Blastoids Modeling Blastocyst Development and Implantation
12:09

Protocol for Human Blastoids Modeling Blastocyst Development and Implantation

Published on: August 10, 2022

7.3K
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

13.1K

科学领域:

  • 生命科学 生命科学
  • 生物伦理学生物伦理学
  • 监管科学 监管科学

背景情况:

  • 基于干细胞的胚胎模型 (SCBEMs) 的快速进步需要进行伦理和监管审查.
  • SCBEM的研究与人类胚胎和生殖研究中的伦理考虑相似.
  • 关于SCBEMs的开发和应用出现了规范性问题.

研究的目的:

  • 调查围绕SCBEMs的伦理和规范问题.
  • 概述潜在的答案,并讨论对全球监管发展的影响.
  • 检查负责SCBEM研究的治理框架.

主要方法:

  • 文献综述和SCBEM研究的伦理分析.
  • 绘制主要的伦理问题和进一步辩论的领域.
  • 审查现有和拟议的治理框架.

主要成果:

  • 在SCBEM研究中确定关键的伦理挑战.
  • 对规范性问题和潜在解决方案的调查.
  • 对负责任创新的治理需求的分析.

结论:

  • 为指导SCBEM研究的建议包括仔细规划,透明沟通和包容性对话.
  • 强有力的治理和持续的经验调查对于道德健全性至关重要.
  • 实施这些措施将促进公众的信任和负责任的科学进步.